What Is Latisse?

Latisse (bimatoprost ophthalmic solution 0.03%) is an FDA-approved prescription treatment for hypotrichosis of the eyelashes — a condition where eyelashes are inadequate or insufficient. It is manufactured by AbbVie (formerly Allergan) and works by increasing eyelash growth, making lashes longer, thicker, and darker.

Latisse is the only FDA-approved prescription treatment specifically for eyelash growth. It is a prostaglandin analog that extends the active growth phase of the eyelash hair cycle. Results are typically visible at 8 weeks, with full results at 16 weeks of consistent nightly use.

Latisse is also sometimes used off-label for eyebrow enhancement and eyelash regrowth after chemotherapy.

How Does Latisse Work?

Latisse contains bimatoprost, a synthetic prostamide analog structurally related to prostaglandin F2-alpha. It promotes eyelash growth by prolonging the anagen (active growth) phase of the eyelash hair cycle, which results in longer lashes. It also increases the number of hairs produced during this phase, leading to thicker, fuller lashes.

The exact mechanism involves stimulation of hair follicle cells via prostamide receptors, though the full pathway is not completely understood. Bimatoprost was originally developed as a glaucoma treatment (marketed as Lumigan), and enhanced eyelash growth was discovered as a beneficial side effect.

Continuous use is required to maintain results — if you stop applying Latisse, eyelashes will gradually return to their pre-treatment appearance over several weeks to months.

What Doses Are Available for Latisse?

• Bimatoprost ophthalmic solution 0.03% (3 mL bottle) — typically a 30-day supply, includes disposable sterile applicators.
• Bimatoprost ophthalmic solution 0.03% (5 mL bottle) — approximately a 60-day supply, includes disposable sterile applicators.

Latisse is applied once nightly — one drop per disposable applicator, applied along the upper eyelid lash line. A new applicator is used for each eye. Do not apply to the lower eyelid.

How Hard Is It to Find Latisse in Stock?

Latisse currently has a findability score of 72 out of 100, meaning it is moderately easy to find at most pharmacies. There is no active shortage of Latisse or generic bimatoprost 0.03% ophthalmic solution. Brand-name Latisse is widely stocked at major retail pharmacies and can also be obtained through dermatology and aesthetic medicine offices.

If your local pharmacy doesn't carry Latisse or generic bimatoprost, try using Medfinder to search pharmacies near you that currently have it in stock. Independent pharmacies and compounding pharmacies may also carry generic alternatives.

Who Can Prescribe Latisse?

Since Latisse is not a controlled substance, any licensed prescriber can write a prescription. Common prescribing specialties include:

• Dermatologists — the most common prescribers of Latisse
• Ophthalmologists — especially familiar with bimatoprost from its glaucoma use
• Plastic Surgeons — often prescribe as part of aesthetic treatment plans
• Aesthetic Medicine Providers — medical spas and cosmetic clinics
• Primary Care Physicians

Latisse is also available through telehealth platforms, making it easy to get a prescription without an in-person visit. Use Medfinder to find providers and pharmacies near you.

Is Latisse a Controlled Substance?

No. Latisse is not a controlled substance and has no DEA scheduling. It does not produce euphoria, has no abuse potential, and is not addictive. However, it does require a prescription because it is an FDA-regulated medication with potential side effects that need medical oversight, including possible changes to iris pigmentation and periorbital fat atrophy with prolonged use.

Common Side Effects of Latisse

Most side effects of Latisse are mild and localized. The most commonly reported include:

• Eye itching (pruritus) — approximately 4% of users
• Eye redness (conjunctival hyperemia) — approximately 3%
• Eyelid skin darkening (hyperpigmentation) — approximately 3%
• Eye irritation
• Dry eyes
• Eyelid redness (erythema)

More serious but rare side effects include iris pigmentation change (which may be permanent and is more likely in people with mixed-color irises), periorbital fat atrophy (a sunken appearance around the eyes with prolonged use), macular edema, and intraocular inflammation. Hair growth may also occur on skin areas where Latisse solution repeatedly contacts. Always apply carefully and blot excess solution.

Alternative Medications to Latisse

If you cannot find Latisse in stock or are looking for more affordable options, consider these alternatives:

• Generic Bimatoprost 0.03% — The same active ingredient as Latisse, available from multiple generic manufacturers at significantly lower cost ($35–$130 vs. $180–$280 for brand).
• Lumigan (Bimatoprost 0.01%) — FDA-approved for glaucoma, sometimes used off-label for lash growth. Contains the same active ingredient at a lower concentration.
• RevitaLash Advanced — An over-the-counter eyelash conditioning serum containing peptides and biotin. Not a prescription medication and results may vary.
• GrandeLASH-MD — An over-the-counter lash enhancing serum with vitamins, peptides, and amino acids. Not FDA-approved for lash growth.

Always consult your prescriber before switching treatments. For help finding Latisse or its alternatives, visit Medfinder.

Drug Interactions with Latisse

Latisse has relatively few drug interactions. Notable ones include:

• IOP-lowering prostaglandin analogs (e.g., Lumigan, Xalatan/latanoprost, Travatan/travoprost) — Concurrent use with Latisse may decrease the IOP-lowering effect or cause paradoxical intraocular pressure elevation. Inform your eye doctor if you use glaucoma drops.
• Other ophthalmic medications — If you use other eye drops, separate administration by at least 5 minutes to avoid dilution or interaction.

There are no known food interactions with Latisse. Because bimatoprost is applied topically to the eyelid and has minimal systemic absorption, drug interactions are uncommon.

Final Thoughts on Latisse

Latisse remains the gold standard for prescription eyelash growth treatment in 2026. With a findability score of 72 out of 100, it is generally available at most pharmacies, and the addition of generic bimatoprost options has made this treatment more accessible and affordable than ever.

The biggest barrier for most patients is cost rather than availability — since Latisse is considered cosmetic, most insurance plans won't cover it. However, generic bimatoprost can be found for as low as $35–$60 with discount coupons, and AbbVie's Allē loyalty program offers $30 off brand-name Latisse.

If you're looking for Latisse or generic bimatoprost at the best price near you, use Medfinder to compare availability and find pharmacies that have it in stock.